EPISODE · Aug 26, 2016 · 11 MIN
Big pharma still makes billions after patents lapse
from FT News in Focus
Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an FT analysis. David Crow and Sujeet Indap discuss the findings. Hosted on Acast. See acast.com/privacy for more information.
Embed this episode
NOW PLAYING
Big pharma still makes billions after patents lapse
0:00
11:01
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of FT News in Focus?
This episode is 11 minutes long.
When was this FT News in Focus episode published?
This episode was published on August 26, 2016.
Can I download this FT News in Focus episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!